ATAI — ATAI Life Sciences NV Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual cashflow statement for ATAI Life Sciences NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-24.4	-179	-174	-157	-43.9
Depreciation
Deferred Taxes
Non-Cash Items	16.7	153	119	51	-48
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-0.126	4.45	-7.6	-3.33	7.47
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-7.85	-20.8	-63.2	-104	-84.1
Capital Expenditures	-0.019	-0.059	-1.13	-1.02	-0.59
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	-9.01	-28.2	-80.1	-85.8	-52.7
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-9.03	-28.3	-81.3	-86.8	-53.3
Financing Cash Flow Items	-2.29	-2.01	-9.93	-1.75	-8.58
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	40.4	113	410	20.8	-8.36
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	23.1	67.2	265	-172	-146